Group 1 - The core point of the article is that Dengkang Oral Care announced its investment plan for 2026 during the board meeting held on December 8, 2025, and reported its revenue composition for the first half of 2025, with personal care products accounting for 99.89% of total revenue [1] - As of the report, Dengkang Oral Care has a market capitalization of 6.1 billion yuan [1] - The company’s revenue from personal care products, specifically washing and care products, dominates its business model, indicating a strong focus on this segment [1] Group 2 - The article also highlights a significant issue in the pharmaceutical industry, reporting the first case of pregabalin abuse leading to addiction in China, raising concerns about the accessibility of prescription drugs without proper medical records [1] - The discussion around the regulation of such drugs is ongoing, emphasizing the need for scientific evaluation before making decisions on their control [1]
登康口腔：12月8日召开董事会会议